Table 7.
Diagnosis | Morphology | IHC | Common Genetic Alterations |
---|---|---|---|
Melanoma | Diverse growth patterns; large, atypical spindle-epithelioid-bizarre cells with vesicular nuclei and prominent, eosinophilic nucleoli; nuclear pseudo-inclusions; abundant eosinophilic-clear cytoplasm; and melanin pigment | S100, SOX10, Melan-A, HMB45, and MITF | Diverse: ARID2, BAP1, BRAF, GNAQ, HRAS, KIT, NF1, NRAS, PTEN mutations; and chromosomal gains/losses |
Epithelioid Schwannoma | Multilobulated growth; encapsulated; nests or single cells; variableschwannoma epithelioid cells; and myxoid-hyalinized stroma |
S100, SOX10, Loss of INI1 (~40%) | Loss of SMARCB1 (~40%) |
Myoepithelial tumors | Divers spectrum; reticular/trabecular pattern; variable spindle/epithelioid/clear/plasmocytoid/rhabdoid cells; rarely ductal component (mixed tumors); fibromyxoid stroma; and hyalinization | Pankeratins, S100, SOX10, EMA, GFAP, P63, SMA, calponin, and desmin (focal) | EWSR1 rearrangements (various fusion partners); PLAG1 rearrangements (mixed tumors) |